National Registry of Cardioneuroablation in Recurrent Reflex Syncope
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorUniversity Hospital, Bordeaux
About this trial
This registry aims to collect patient data on cardioneuroablation for vasovagal syncope from multiple centers in France. The aim is to evaluate success rates, compare techniques and help institutions set up their own cardioneuroablation program
Eligibility criteria
Qualifiers
Patients aged 18 or more
Recurrent vasovagal syncope (≥2 episodes during the last year) with an asystolic component (≥3 second pause) recorded during a spontaneous episode. The asystole can be related to sinus arrest or paroxysmal AV block.
Scheduled cardioneuroablation procedure
Estimated residual battery life ≥ 1 year.
Disqualifiers
Contraindication to anticoagulation therapy: major bleeding, risk of major bleeding, severe hepatic disease
Contraindication to cardiac CT: contrast medium allergies
Intracardiac thrombus
Patient detained by judicial or administrative decision.
Trial design
Treatments tested in this trial
- Cardioneuroablation
Treatment groups
50 Participants
are divided into 1 treatment groupLocations
14Hôpital Louis Pradel69500, Bron France
CHU Clermont-Ferrand63000, Clermont-Ferrand France
CHU Lille59000, Lille France
Hôpital de la Timone13385, Marseille France
Sponsors and collaborators
University Hospital, Bordeaux
Lead sponsor
Source ClinicalTrials.gov